HM Hospitales is a leading private hospital group in Spain, committed to providing high-quality healthcare to patients. With a strong focus on innovation and research, HM Hospitales has established itself as a pioneer in medical advancements and personalized treatments.
At the heart of HM Hospitales’ research efforts is the HM Hospitales Research Foundation. Founded in 2003, the foundation is a non-profit organization dedicated to promoting and developing biomedical research, with the ultimate goal of improving patient care. The foundation’s activities encompass a wide range of areas, including clinical research, translational research, and basic research.
The HM Hospitales Research Foundation works closely with the group’s hospitals and medical professionals to identify unmet medical needs and develop innovative solutions. The foundation’s research initiatives focus on various therapeutic areas, such as oncology, cardiology, neurology, and infectious diseases. By fostering collaboration between researchers and clinicians, the foundation ensures that research findings are rapidly translated into clinical practice, benefiting patients directly.
HM Hospitales Research Foundation boasts state-of-the-art facilities and cutting-edge technologies, enabling researchers to conduct advanced studies and clinical trials. The foundation’s research teams comprise highly skilled professionals, including physicians, scientists, and technicians, who are committed to pushing the boundaries of medical knowledge.
In addition to its research activities, the HM Hospitales Research Foundation is actively involved in educating and training future healthcare professionals. The foundation offers various programs and courses aimed at fostering research skills and promoting scientific excellence among medical students and young doctors.
HM Hospitales’ commitment to research and innovation is evident in its numerous achievements and contributions to the medical field. The group’s research efforts have led to the development of new diagnostic tools, treatment protocols, and medical devices, improving the lives of countless patients. HM Hospitales Research Foundation’s dedication to advancing medical knowledge and translating research findings into clinical practice makes it a key player in the Spanish healthcare landscape.
Role of institution in the project
HM Hospitales is involved in the EUCAIM (European Cancer Imaging Initiative) infrastructure, specifically in Work Package 7 (WP7) as a data providencia. With its renowned Clara Campal Comprehensive Cancer Center and state-of-the-art radiodiagnostic services, HM Hospitales brings its expertise in oncological patient care to this European initiative. The group’s participation in EUCAIM underscores its commitment to collaborative research and its focus on leveraging advanced imaging technologies for improved cancer diagnosis and treatment. HM Hospitales’ involvement in EUCAIM further solidifies its position as a leading institution in cutting-edge medical research and its dedication to advancing patient care in oncology.
Dr. César Muñoz, Steering Committee Representative from HM hospitales, medical oncologist specialized in the treatment of GI tumors. He graduated in Medicine from the Autonomous University of Madrid and specialized in Medical Oncology at the 12 de Octubre Hospital in Madrid. Dr. Muñoz is an expert in the management of antineoplastic drugs and has extensive knowledge of his pharmacokinetics and interactions with other drugs. In addition to his care work, Dr. Muñoz actively participates in the emotional, social and psychological support that cancer patients and their families need. Dr. Muñoz exercises his profession in HM Hospitales, a leading institution in the avant -garde of research and cancer treatment. HM Hospitales has the Clara Campal Comprehensive Cancer Center, a reference center in the treatment of cancer that offers patients the best care and the most innovative treatments.